Home
Market Capitalization of Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd
NSE: LINCOLN
Market Cap
Key Highlights
- The Market Cap of Lincoln Pharmaceuticals Ltd is ₹ 1135 crore as of 21 Feb 25 .
- The Latest Trading Price of Lincoln Pharmaceuticals Ltd is ₹ 566.85 as of 21 Feb 15:30 .
- The dividend payouts of Lincoln Pharmaceuticals Ltd changed from ₹ 1.5 to ₹ 1.8 over 6 quarters. This represents a CAGR of 12.92% .

Lincoln Pharmaceuticals Ltd
NSE: LINCOLN
Share Price
Market Price of Lincoln Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 566.85 |
20 Feb 2025 | 564.05 |
19 Feb 2025 | 569.55 |
18 Feb 2025 | 564.45 |
17 Feb 2025 | 573.8 |
14 Feb 2025 | 560.35 |
13 Feb 2025 | 641.8 |
12 Feb 2025 | 664.9 |
11 Feb 2025 | 680.5 |
10 Feb 2025 | 710.9 |
SWOT Analysis Of Lincoln Pharmaceuticals Ltd
BlinkX Score for Lincoln Pharmaceuticals Ltd
Asset Value vs Market Value of Lincoln Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Lincoln Pharmaceuticals Ltd
Historical P/E Ratio of Lincoln Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Lincoln Pharmaceuticals Ltd
Historical Revenue of Lincoln Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Lincoln Pharmaceuticals Ltd
Historical EBITDA of Lincoln Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Lincoln Pharmaceuticals Ltd
Historical Net Profit of Lincoln Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Lincoln Pharmaceuticals Ltd
Historical Dividend Payouts of Lincoln Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Lincoln Pharmaceuticals Ltd
About Lincoln Pharmaceuticals Ltd
- Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95.
- All the assets and business of the erstwhile partnership were transferred to the Company.
- The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
- The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982.
- It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments.
Lincoln Pharmaceuticals Ltd News Hub
Lincoln Pharmaceuticals consolidated net profit rises 24.51% in the June 2024 quarter
Net profit of Lincoln Pharmaceuticals rose 24.51% to Rs 23.67 crore in the quarter ended June 2024 a
Read more
09 Aug 24
Lincoln Pharmaceuticals AGM scheduled
Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held
Read more
03 Sept 24
Lincoln Pharmaceuticals announces board meeting date
Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November
Read more
07 Nov 24
Lincoln Pharmaceuticals to conduct AGM
Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held
Read more
03 Sept 24